Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Itepekimab for COPD
Recruiting1 awardPhase 3
Tampa, Florida
This trial will compare itepekimab to placebo in smokers with COPD to see if it reduces exacerbations and improves pulmonary function.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.